Zydus Lifesciences schedules investor roadshow in Singapore and Hong Kong

0 min read     Updated on 17 Aug 2026, 04:56 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Zydus Lifesciences Limited confirmed a non-deal roadshow in Singapore and Hong Kong from August 24 to 26, 2026. The disclosure was filed with BSE and NSE on August 17, 2026, by Company Secretary Dhaval N. Soni.

powered bylight_fuzz_icon
48511594

*this image is generated using AI for illustrative purposes only.

Zydus Lifesciences Limited will hold a non-deal roadshow in Singapore and Hong Kong from August 24 to 26, 2026. The management team plans to meet with investors during this period to discuss the company's outlook and operations.

The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the event. Dhaval N. Soni, Company Secretary and Compliance Officer, signed the disclosure on August 17, 2026.

Event Details

The non-deal roadshow is scheduled for three days in late August. The specific locations are Singapore and Hong Kong.

Detail Information
Event Type Non-Deal Roadshow
Dates August 24-26, 2026
Locations Singapore, Hong Kong
Announced On August 17, 2026

Historical Stock Returns for Zydus Life Science

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%+1.55%-0.19%+24.28%+14.43%+112.69%

How might the insights shared during the Singapore and Hong Kong roadshow influence Zydus Lifesciences' valuation among Asian institutional investors?

What specific growth strategies or pipeline updates is Zydus likely to highlight to attract capital in these key financial hubs?

Could this non-deal roadsignal an upcoming strategic move, such as a potential merger, acquisition, or new debt issuance in the near future?

Zydus Lifesciences reschedules Motilal Oswal investor conference to Aug 17

1 min read     Updated on 12 Aug 2026, 08:42 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Zydus Lifesciences Limited has moved its appearance at the Motilal Oswal 22nd Annual Global Investor Conference from August 18 to August 17, 2026. The company issued this clarification through a filing dated August 12, 2026, superseding its earlier communication from August 10. Investors are advised to note the one-day shift in the schedule for management interactions.

powered bylight_fuzz_icon
47882445

*this image is generated using AI for illustrative purposes only.

Zydus Lifesciences Limited has rescheduled its participation in the Motilal Oswal 22nd Annual Global Investor Conference to August 17, 2026. The pharmaceutical firm originally planned to engage with investors on August 18, 2026, as disclosed in an earlier intimation filed on August 10, 2026. This update ensures stakeholders are aware of the revised timeline for management interaction regarding strategic direction and business updates.

The revised disclosure was filed with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on August 12, 2026. The filing serves to correct the previous information and aligns market participants with the actual event schedule.

Event Details

The conference is organized by Motilal Oswal Financial Services. Zydus Lifesciences will now take part in the proceedings on August 17, 2026, instead of the previously announced August 18 date. The company did not specify a particular time slot or session format in the update.

Event Name Original Date Revised Date Organizer
Motilal Oswal 22nd Annual Global Investor Conference August 18, 2026 August 17, 2026 Motilal Oswal

Regulatory Compliance

The announcement was authorized by Dhaval Narendra Soni, Company Secretary and Compliance Officer of Zydus Lifesciences Limited. The filing carries membership number FCS7063 and was digitally signed on August 12, 2026, at 4:57 pm.

Zydus Lifesciences Limited maintains its registered office at 'Zydus Corporate Park', Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, S. G. Highway, Ahmedabad-382 481, Gujarat, India. The company’s Corporate Identification Number (CIN) is L24230GJ1995PLC025878.

Historical Stock Returns for Zydus Life Science

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%+1.55%-0.19%+24.28%+14.43%+112.69%

What specific strategic updates or pipeline developments is Zydus Lifesciences likely to highlight during the rescheduled conference session?

Could the one-day schedule change indicate any internal operational adjustments or broader logistical shifts at the Motilal Oswal conference?

How might this revised timeline impact short-term trading volume or investor sentiment ahead of the August 17 event?

More News on Zydus Life Science

1 Year Returns:+14.43%